{
    "id": "351feec9-208b-e74a-e063-6394a90aa399",
    "indications": "quetiapine atypical antipsychotic indicated treatment : · schizophrenia ( 1.1 ) · bipolar disorder manic episodes ( 1.2 ) · bipolar disorder , depressive episodes ( 1.2 )",
    "contraindications": "· quetiapine tablets , usp taken without food ( 2.1 ) indication initial dose recommended dose maximum dose schizophrenia-adults ( 2.2 ) 25 mg twice daily 150 750 mg/day 750 mg/day schizophrenia-adolescents ( 13 17 years ) ( 2.2 ) 25 mg twice daily 400 800 mg/day 800 mg/day bipolar mania- adults monotherapy adjunct lithium divalproex ( 2.2 ) 50 mg twice daily 400 800 mg/day 800 mg/day bipolar mania- children adolescents ( 10 17 years ) , monotherapy ( 2.2 ) 25 mg twice daily 400 600 mg/day 600 mg/day bipolar depression-adults ( 2.2 ) 50 mg daily bedtime 300 mg/day 300 mg/day · geriatric : consider lower starting dose ( 50 mg/day ) , slower titration careful monitoring initial dosing period elderly ( 2.3 , 8.5 ) · hepatic impairment : lower starting dose ( 25 mg/day ) slower titration may needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions": "quetiapine tablets , usp 400 mg yellow coloured , film coated , capsule shaped , biconvex tablets , debossed `` 336 `` one side plain side . ndc : 71335-2394-1 : 30 tablets bottle ndc : 71335-2394-2 : 28 tablets bottle ndc : 71335-2394-3 : 60 tablets bottle ndc : 71335-2394-4 : 180 tablets bottle ndc : 71335-2394-5 : 90 tablets bottle store 20° 25°c ( 68° 77°f ) ; excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "hypersensitivity quetiapine excipients quetiapine formulation . anaphylactic reported patients treated quetiapine .",
    "ingredients": [
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "POLYETHYLENE GLYCOL 4000",
            "code": "4R4HFI6D95"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "QUETIAPINE FUMARATE",
            "code": "2S3PL1B6UJ"
        }
    ],
    "organization": "Bryant Ranch Prepack",
    "name": "Quetiapine Fumarate",
    "effectiveTime": "20250514",
    "indications_original": "Quetiapine is an atypical antipsychotic indicated for the treatment of: ·         Schizophrenia ( 1.1 ) ·         Bipolar I disorder manic episodes ( 1.2 ) ·         Bipolar disorder, depressive episodes ( 1.2 )",
    "contraindications_original": "·         Quetiapine tablets, USP can be taken with or without food ( 2.1 ) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia-Adults (2.2) 25 mg twice daily 150 to 750 mg/day 750 mg/day Schizophrenia-Adolescents (13 to 17 years) (2.2) 25 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Adults Monotherapy or as an adjunct to lithium or divalproex (2.2) 50 mg twice daily 400 to 800 mg/day 800 mg/day Bipolar Mania- Children and Adolescents (10 to 17 years), Monotherapy (2.2) 25 mg twice daily 400 to 600 mg/day 600 mg/day Bipolar Depression-Adults (2.2) 50 mg once daily at bedtime 300 mg/day 300 mg/day · Geriatric Use: Consider a lower starting dose (50 mg/day), slower titration and careful monitoring during the initial dosing period in the elderly ( 2.3 , 8.5 ) · Hepatic Impairment: Lower starting dose (25 mg/day) and slower titration may be needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions_original": "Quetiapine tablets, USP 400 mg\n                  Yellow coloured, film coated, capsule shaped, biconvex tablets, debossed with \"336\" on one side and plain on other side.\n                  \n                  \n                     NDC: 71335-2394-1: 30 TABLETs in a BOTTLE\n                     NDC: 71335-2394-2: 28 TABLETs in a BOTTLE\n                     NDC: 71335-2394-3: 60 TABLETs in a BOTTLE\n                     NDC: 71335-2394-4: 180 TABLETs in a BOTTLE\n                     NDC: 71335-2394-5: 90 TABLETs in a BOTTLE\n                  \n                  Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].\n                  Repackaged/Relabeled by: \n    Bryant Ranch Prepack, Inc. \n    Burbank, CA 91504",
    "adverseReactions_original": "Hypersensitivity to quetiapine or to any excipients in the quetiapine formulation. Anaphylactic reactions have been reported in patients treated with quetiapine."
}